Janet Dunn

Professor of Clinical Trials and Head of Cancer trials

University of Warwick

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom Professors in Medical Imaging Medical Imaging professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Professor Janet Dunn is a distinguished faculty member at the University of Warwick, located in the United Kingdom. She serves as the Head of Cancer Trials, focusing her research on clinical trials related to breast cancer and multiple myeloma. Her recent publications highlight significant contributions to the evaluation of mammographic surveillance strategies and the implementation of multi-omic machine learning approaches in assessing therapy responses for cancer patients.

Articles (13)

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

View details

Richard Neal

University of Exeter

UNITED KINGDOM

View details

Kamaraj Karunanithi

UNITED KINGDOM

View details

Catherine Atkin

NIHR Academic Clinical Lecturer

University of Birmingham

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Janet Dunn

Research Interests

Explore related searches

Contact this professor

About

Articles (13)

Quality of life and patient reported outcomes in the UK Mammo-50 randomised trial of annual versus less frequent mammographic surveillance in people with breast cancer aged 50 years and over

Annual versus less frequent mammographic surveillance in people with breast cancer aged 50 years and older in the UK (Mammo-50): a multicentre, randomised, phase 3, non-inferiority trial

Mammographic surveillance after breast cancer

Presenting Symptoms in Newly Diagnosed Myeloma, Relation to Organ Damage, and Implications for Symptom-Directed Screening: A Secondary Analysis from the Tackling Early Morbidity and Mortality in Myeloma (TEAMM) Trial

Multi-omic machine learning predictor of breast cancer therapy response.

Comparative survival analysis of multiparametric tests-when molecular tests disagree-A TEAM Pathology study.

Improvement in Dysphagia Outcomes Following Clinical Target Volume Reduction in the De-ESCALaTE Study

Development and validation of an improved classification and risk stratification system for carotid body tumors: Multinational collaborative cohort study

Low serum 1,25(OH)2D3 in end-stage renal disease: is reduced 1α-hydroxylase the only problem?

Commentary on: Introduction of an abbreviated breast MRI service in the UK as part of the BRAID trial: practicalities, challenges, and future directions

Diagnostic pathways in multiple myeloma and their relationship to end organ damage: an analysis from the Tackling Early Morbidity and Mortality in Myeloma (TEAMM) trial

Hypofractionated chemoradiation for head and cancer: Data from the PET NECK trial

The potential utility of abbreviated breast MRI (FAST MRI) as a tool for breast cancer screening: a systematic review and meta-analysis

Collaborators (9)

Kwee Yong

Robert Stein

Helena Earl

Gulnaz Iqbal

Mark Drayson

Guy Pratt

Richard Neal

Kamaraj Karunanithi

Catherine Atkin

Make your next move.